Federal Law May Push Drugmakers Who Hesitated To Participate In California’s ‘Right-To-Try’ Law
The federal law provides broader legal protections for drug companies than does California, and it limits the the Food and Drug Administration's access to data collected through patients who seek the experimental drugs.
Capital Public Radio:
Federal Right To Try Law Could Mean More Access — And Risk — For California Patients
California’s Right to Try law is supposed to give terminally ill patients access to drugs that haven’t been fully approved by the U.S. Food and Drug Administration. Since it was enacted in 2017 drug companies have been reluctant to participate. A new federal law signed by President Donald Trump Wednesday could solve that problem, but opponents say it will undermine the FDA’s crucial drug-vetting process. (Caiola, 5/31)
'Right-To-Try' Intended To Weaken FDA, Key Senator Says In Blunt Remarks
Sen. Ron Johnson, the author of the federal “right-to-try” law signed by President Trump this week, wants to make one thing clear: His new law is meant to weaken the Food and Drug Administration. “This law intends to diminish the FDA’s power over people’s lives, not increase it,” he wrote in a letter to Commissioner Scott Gottlieb Thursday. (Mershon, 5/31)